We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Wavefront Analisys and Contrast Sensitivity of Spherical and Aspherical Intraocular Lenses

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00347243
Recruitment Status : Completed
First Posted : July 4, 2006
Last Update Posted : October 26, 2006
Information provided by:

Study Description
Brief Summary:
Purpose:To compare visual performance, total and high order wavefront aberrations (coma, spherical aberration and other terms) and contrast sensitivity in eyes implanted with one monofocal aspheric intraocular lens (IOL) and two spherical IOLs (SofPort AO, Soflex,AcrySof®IQ (40 eyes), AcrySof®Natural and AMO®Sensar)

Condition or disease Intervention/treatment Phase
Cataract Pseudophakia Procedure: phacoemulsification (cataract surgery) Phase 4

Study Design

Study Type : Interventional  (Clinical Trial)
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double
Primary Purpose: Treatment
Official Title: Wavefront Analisys and Contrast Sensitivity of Spherical and Aspherical
Study Start Date : September 2005
Estimated Study Completion Date : June 2006

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Cataract
U.S. FDA Resources

Arms and Interventions

Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   50 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Patients with bilateral visually significant senile cataract, corneal astigmatism less than 2.0 diopters and potential acuity meter (PAM) better than 0.2 LogMar

Exclusion Criteria:

  • any other ocular diseases, such as corneal opacities or irregularity, dry eye, amblyopia, anisometropia, glaucoma, retinal abnormalities, surgical complications, IOL tilt, decentration (estimated by retro illumination and digital photo) greater than 0.4mm13 or loss of follow-up
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00347243

Federal University of Sao paulo
Sao Paulo, SP, Brazil, 04044-020
Sponsors and Collaborators
Federal University of São Paulo
Study Director: Paulo Schor, MD UNIFESP - EPM
More Information

ClinicalTrials.gov Identifier: NCT00347243     History of Changes
Other Study ID Numbers: CEP012/06
First Posted: July 4, 2006    Key Record Dates
Last Update Posted: October 26, 2006
Last Verified: March 2006

Additional relevant MeSH terms:
Lens Diseases
Eye Diseases
Signs and Symptoms